glp-1 forms PDB-101: Molecule of the Month: Receptor Agonists GLP-1 Medications for Weight Loss
Description
I have to try something different
Until recently, GLP-1s were only indicated and marketed for the management of type II diabetes
After adjusting for baseline risk factors, GLP-1 users had significantly lower recurrence rates than those using SGLT2 inhibitors or DPP-4 inhibitors
Tirzepatide acts on both GLP-1 and GIP receptors and often produces faster, larger weight loss for many people
No GLP-1 medication has definitively fewer side effects across all userstolerability is highly individual and shaped by genetic factors, dosing escalation speed, and whether the medication is injected or oral
10.1016/j.japh.2023.10.002
